CoreValve is a private company founded in 2001 by Jacques Seguin, M.D., Ph.D., a cardiac surgeon.  The vision of the Company was to develop a technology that permits the replacement of failing aortic heart valves without surgical access.  Developing the concept of a catheter-based aortic valve replacement procedure, the Company has rapidly advanced this technology from vision to reality.  Today, more than 700 patients have experienced successful aortic valve replacement with the CoreValve  procedure.

CoreValve  objective is to be the technological, clinical, and market leader in percutaneous heart valve replacement therapies.  Current efforts are focused on percutaneous aortic valve replacement, but future efforts will relate to other minimally invasive structural heart disease treatments.  CoreValve  headquarters’ are in Irvine, California, an area renowned for the development of innovative heart valve technologies.